177 related articles for article (PubMed ID: 7684650)
1. Relationship between prostate specific antigen, prostate volume and age in the benign prostate.
Collins GN; Lee RJ; McKelvie GB; Rogers AC; Hehir M
Br J Urol; 1993 Apr; 71(4):445-50. PubMed ID: 7684650
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum prostate specific antigen concentration and prostate volume.
Yu HJ; Chiang GJ; Chiu TY; Lai MK
J Formos Med Assoc; 1995 Nov; 94(11):666-70. PubMed ID: 8527973
[TBL] [Abstract][Full Text] [Related]
4. Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable?
Morote J; Encabo G; López M; de Torres IM
Eur Urol; 2000 Jul; 38(1):91-5. PubMed ID: 10859448
[TBL] [Abstract][Full Text] [Related]
5. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
6. Relationship between prostate-specific antigen, prostate volume, retention volume and age in benign prostatic hypertrophy (BPH).
Dutkiewicz S; Witeska A; Stepień K
Int Urol Nephrol; 1995; 27(6):763-8. PubMed ID: 8725044
[TBL] [Abstract][Full Text] [Related]
7. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study.
Bosch JL; Bohnen AM; Groeneveld FP
Eur Urol; 2004 Dec; 46(6):753-9. PubMed ID: 15548443
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
9. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
10. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
11. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
[TBL] [Abstract][Full Text] [Related]
12. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
[TBL] [Abstract][Full Text] [Related]
13. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
[TBL] [Abstract][Full Text] [Related]
14. [The relationship of PSA to age and prostatic volume in patients with benign prostatic hypertrophy].
Sánchez Sánchez E; Paez Borda A; Herrero Payo A; Ruiz Rubio JL; Acebal Lucía J; Berenguer Sánchez A
Actas Urol Esp; 1995 Mar; 19(3):181-6. PubMed ID: 8659273
[TBL] [Abstract][Full Text] [Related]
15. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
Chung BH; Hong SJ; Cho JS; Seong DH
BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
[TBL] [Abstract][Full Text] [Related]
18. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.
Bosch JL; Hop WC; Bangma CH; Kirkels WJ; Schröder FH
Prostate; 1995 Nov; 27(5):241-9. PubMed ID: 7479391
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.
Semjonow A; Hamm M; Rathert P; Hertle L
Br J Urol; 1994 May; 73(5):538-43. PubMed ID: 7516808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
